Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2085-2096

  Valenti, Daniela ^a   De Bari, Lidia ^a   Manente, Gabriella Arcangela ^b   Rossi, Leonardo ^c   Mutti, Luciano ^d   Moro, Laura ^b   Vacca, Rosa Anna ^a  

^a CNR   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d Vercelli Hospital   (Italy)

Author keywords

EGCG; Malignant mesothelioma; Mitochondria; OXPHOS inhibition; STAT3

Indexed keywords

CATALASE; CYTOCHROME C; EPIGALLOCATECHIN GALLATE; HYDROGEN PEROXIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; BIOENERGY; CELL ENERGY; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MESOTHELIUM CELL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULE; OXIDATIVE PHOSPHORYLATION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY CHAIN; SWELLING; TARGET CELL; ULTRASTRUCTURE;

EID: 84883289236     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.07.014     Document Type: Article

References (58)

1. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11:325-337.
2. Weinberg F., Hamanaka R., Wheaton W.W., Weinberg S., Joseph J., Lopez M., Kalyanaraman B., Mutlu G.M., Budinger G.R., Chandel N.S. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8788-8793.
3. Whitaker-Menezes D., Martinez-Outschoorn U.E., Flomenberg N., Birbe R.C., Witkiewicz A.K., Howell A., Pavlides S., Tsirigos A., Ertel A., Pestell R.G., Broda P., Minetti C., Lisanti M.P., Sotgia F. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 2011, 10:4047-4064.
4. Barbi de Moura M., Vincent G., Fayewicz S.L., Bateman N.W., Hood B.L., Sun M., Suhan J., Duensing S., Yin Y., Sander C., Kirkwood J.M., Becker D., Conrads T.P., Van Houten B., Moschos S.J. Mitochondrial respiration-an important therapeutic target in melanoma. PLoS One 2012, 7:e40690.
5. Li Y., Li D., Yuan S., Wang Z., Tang F., Nie R., Weng J., Ma L., Tang B. Embelin-induced MCF-7 breast cancer cell apoptosis and blockade of MCF-7 cells in the G2/M phase via the mitochondrial pathway. Oncol. Lett. 2013, 5:1005-1009.
6. Cunniff B., Benson K., Stumpff J., Newick K., Held P., Taatjes D., Joseph J., Kalyanaraman B., Heintz N.H. Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells. J. Cell. Physiol. 2013, 228:835-845.
7. Campbell N.P., Kindler H.L. Update on malignant pleural mesothelioma. Semin. Respir. Crit. Care Med. 2011, 32:102-110.
8. Piyaviriyakul S., Shimizu K., Asakawa T., Kan T., Siripong P., Oku N. Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs. Biol. Pharm. Bull. 2011, 34:396-400.
9. Hsu S., Lewis J., Singh B., Schoenlein P., Osaki T., Athar M., Porter A.G., Schuster G. Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis. Anticancer. Res. 2003, 23:1533-1539.
10. Kanwar J., Taskeen M., Mohammad I., Huo C., Chan T.H., Dou Q.P. Recent advances on tea polyphenols. Front Biosci. 2012, 4(2012):111-131.
11. Patra S.K., Rizzi F., Silva A., Rugina D.O., Bettuzzi S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. Physiol. Pharmacol. 2008, 59:217-235.
12. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011, 82:1807-1821.
13. Qanungo S., Das M., Haldar S., Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 2005, 26:958-967.
14. Kil I.S., Jung K.H., Nam W.S., Park J.W. Attenuated mitochondrial NADP+ -dependent isocitrate dehydrogenase activity enhances EGCG-induced apoptosis. Biochimie 2011, 93:1808-1815.
15. 2+ channel opening. J. Cell. Mol. Med. 2012, 16:2667-2678.
16. Satoh M., Takemura Y., Hamada H., Sekido Y., Kubota S. EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy. Cancer Cell Int. 2013, 13:19.
17. Li G.X., Chen Y.K., Hou Z., Xiao H., Jin H., Lu G., Lee M.J., Liu B., Guan F., Yang Z., Yu A., Yang C.S. Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 2010, 31:902-910.
18. Azam S., Hadi N., Khan N.U., Hadi S.M. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol. In Vitro 2004, 18:555-561.
19. Long L.H., Kirkland D., Whitwell J., Halliwell B. Different cytotoxic and clastogenic effects of epigallocatechin gallate in various cell-culture media due to variable rates of its oxidation in the culture medium. Mutat. Res. 2007, 634:177-183.
20. Hou Z., Sang S., You H., Lee M.J., Hong J., Chin K.V., Yang C.S. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 2005, 65:8049-8056.
21. Hong J., Lu H., Meng X., Ryu J.H., Hara Y., Yang C.S. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002, 62:7241-7246.
22. Orengo A.M., Spoletini L., Procopio A., Favoni R.E., De Cupis A., Ardizzoni A., Castagneto B., Ribotta M., Betta P.G., Ferrini S., Mutti L. Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. Eur. Respir. J. 1999, 13:527-534.
23. Smythe W.R., Kaiser L.R., Hwang H.C., Amin K.M., Pilewski J.M., Eck S.J., Wilson J.M., Albelda S.M. Successful adenovirus mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann. Thorac. Surg. 1994, 57:1395-1401.
24. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2'7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5:227-231.
25. Mukhopadhyay P., Rajesh M., Haskó G., Hawkins B.J., Madesh M., Pacher P. Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat. Protoc. 2007, 2:2295-2301.
26. Vacca R.A., Marra E., Loverro G., Maiorano E., Napoli A., Lovecchio M., Selvaggi L., Perlino E. Differential expression of beta 1c integrin messenger ribonucleic acid and protein levels in human endometrium and decidua during the menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab. 2003, 88:720-729.
27. Chelli B., Lena A., Vanacore R., Da Pozzo E., Costa B., Rossi L., Salvetti A., Scatena F., Ceruti S., Abbracchio M.P., Gremigni V., Martini C. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem. Pharmacol. 2004, 68:125-134.
28. Valenti D., Manente G.A., Moro L., Marra E., Vacca R.A. Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. Biochem. J. 2011, 435:679-688.
29. Bénit P., Goncalves S., Philippe Dassa E., Brière J.J., Martin G., Rustin P. Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin. Chim. Acta 2006, 374:81-86.
30. Yang N.C., Ho W.M., Chen Y.H., Hu M.L. A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. Anal. Biochem. 2002, 306:323-327.
31. Valenti D., Tullo A., Caratozzolo M.F., Merafina R.S., Scartezzini P., Marra E., Vacca R.A. Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem. J. 2010, 431:299-310.
32. Walz W., Mukerji S. Lactate production and release in cultured astrocytes. Neurosci. Lett. 1988, 86:296-300.
33. Dröse S., Brandt U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv. Exp. Med. Biol. 2012, 748:145-169.
34. Galluzzi L., Kepp O., Trojel-Hansen C., Kroemer G. Mitochondrial control of cellular life, stress, and death. Circ. Res. 2012, 111:1198-1207.
35. Inacio J.D., Canto-Cavalheiro M.M., Menna-Barreto R.F., Almeida-Amaral E.E. Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis. Exp. Parasitol. 2012, 132:151-155.
36. Monian P., Jiang X. Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. Exp. Oncol. 2012, 34:185-191.
37. Tang S.N., Fu J., Shankar S., Srivastava R.K. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS One 2012, 7:e31067.
38. Szczepanek K., Chen Q., Larner A.C., Lesnefsky E.J. Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion 2012, 12:180-189.
39. Zamaraeva M.V., Sabirov R.Z., Maeno E., Ando-Akatsuka Y., Bessonova S.V., Okada Y. Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death and Differ. 2005, 12:1390-1397.
40. Fassina A., Cappellesso R., Guzzardo V., Dalla Via L., Piccolo S., Ventura L., Fassan M. Epithelial-mesenchymal transition in malignant mesotelioma. Mod. Pathol. 2012, 25:86-99.
41. Atlante A., Giannattasio S., Bobba A., Gagliardi S., Petragallo V., Calissano P., Marra E., Passarella S. An increase in the ATP levels occurs in cerebellar granule cells en route to apoptosis in which ATP derives from both oxidative phosphorylation and anaerobic glycolysis. Biochim. Biophys. Acta 2005, 1708:50-62.
42. Mak C. Potential role of green tea catechins in various disease therapies: progress and promise. Clin. Exp. Pharmacol. Physiol. 2012, 39:265-273.
43. Valenti D., De Rasmo D., Signorile A., Rossi L., de Bari L., Scala I., Granese B., Papa S., Vacca R.A. Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subject with Down's syndrome. Biochim. Biophys. Acta 2013, 1832:542-552.
44. Dragicevic N., Smith A., Lin X., Yuan F., Copes N., Delic V., Tan J., Cao C., Shytle R.D., Bradshaw P.C. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. J. Alzheimers Dis. 2011, 26:507-521.
45. Tanaka M., Zhao J., Suyama A., Matsui T. Epigallocatechin gallate promotes the vasorelaxation power of the antiatherosclerotic dipeptide Trp-His in contracted rat aorta. J. Agric. Food Chem. 2012, 60:9048-9054.
46. Yang C.S., Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol. Nutr. Food Res. 2011, 55:819-831.
47. Lambert J.D., Lee M.J., Diamond L., Ju J., Hong J., Bose M., Newmark H.L., Yang C.S. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 2006, 34:8-11.
48. Sang S., Yang I., Buckley B., Ho C.T., Yang C.S. Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping. Free Radic. Biol. Med. 2007, 43:362-371.
49. Johnston P.A., Grandis J.R. STAT3 signaling: anticancer strategies and challenges. Mol. Interv. 2011, 11:18-26.
50. Achcar Rde O., Cagle P.T., Jagirdar J. Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible role for chemotherapeutic intervention. Arch. Pathol. Lab. Med. 2007, 131:1350-1360.
51. Subramaniam A., Shanmugam M.K., Perumal E., Li F., Nachiyappan A., Dai X., Swamy S.N., Ahn K.S., Kumar A.P., Tan B.K., Hui K.M., Sethi G. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim. Biophys. Acta 2013, 1835:46-60.
52. Demaria M., Giorgi C., Lebiedzinska M., Esposito G., D'Angeli L., Bartoli A., Gough D.J., Turkson J., Levy D.E., Watson C.J., Wieckowski M.R., Provero P., Pinton P., Poli V. A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging (Albany NY) 2010, 2:823-842.
53. Demaria M., Poli V. From the nucleous to the mitochondria and back. The odyssey of a multitask STAT3. Cell Cycle 2011, 10:3221-3222.
54. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
55. Boengler K., Hilfiker-Kleiner D., Heusch G., Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res. Cardiol. 2010, 105:771-785.
56. Xia W., Spector S., Hardy L., Zhao S., Saluk A., Alemane L., Spector N.L. Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7494-7499.
57. Katayama M., Kawaguchi T., Berger M.S., Pieper R.O. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007, 14:548-558.
58. Volta V., Ranzato E., Martinotti S., Gallo S., Russo M.V., Mutti L., Biffo S., Burlando B. Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma. PLoS One 2013, 8:e58051.